NDC 60219-2045-07 - theophylline
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60219-2045
- Requested NDC
- 60219-2045-07
- Package NDCs from labels
- 60219-2045-3, 60219-2045-1, 60219-2045-5, 60219-2045-7, 60219-2045-07
- Manufacturer
- Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited
- Effective date
- 2026-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Theophylline Extended-Release Tablets Rx only | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | 2026-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60219-2045-1 | theophylline | 100 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 100 | 3 | |
| 60219-2045-3 | theophylline | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | 3 | |
| 60219-2045-5 | theophylline | 500 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 500 | 3 | |
| 60219-2045-7 | theophylline | 1000 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 1000 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60219-2045 | THEOPHYLLINE TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS NY LLC] | 3 | Current NDC, 4 package rows | 20230327_b0d5d1cd-c79b-4229-929c-2eb3e4f43298.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60219-2045-1 | EA - Each | 60219-2045 | 92202778-7773-4229-9d96-ce19dc03e1ed | 1 | 2023-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| THEOPHYLLINE | THEOPHYLLINE | Leading Pharma, LLC | ac490ebf-24e1-47c4-a932-ad4dcafe7aad | 2024-10-07 | Warnings, Adverse reactions | 317769 314241 |
| Theo-24 | THEOPHYLLINE ANHYDROUS | ENDO USA, Inc. | 7a108fa0-c230-475f-be93-6f864b98a410 | 2024-07-08 | Warnings, Adverse reactions | 0I55128JYK |
| Theophylline | THEOPHYLLINE | Viona Pharmaceuticals Inc | abdfb9b9-9402-4761-9347-8eb1c4d86242 | 2024-05-22 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
| Theophylline | THEOPHYLLINE | Zydus Lifesciences Limited | 7339f98d-b996-4e20-a7a7-315fd2a9fa4d | 2024-05-22 | 317769 314241 0I55128JYK | |
| Theophylline | THEOPHYLLINE | Harman Finochem Limited | 098db8bb-fa9a-4577-b7d9-86caaefc168a | 2024-04-27 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
| Theophylline | THEOPHYLLINE | Bionpharma Inc., | 63517422-45a0-4e78-8505-eca054068ee9 | 2023-10-12 | Warnings, Adverse reactions | 317769 0I55128JYK |
| Theophylline | THEOPHYLLINE | Camber Pharmaceuticals, Inc. | bf320619-c53b-49a7-97b5-cd0c075a9f75 | 2023-09-20 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
| Theophylline | THEOPHYLLINE | Alembic Pharmaceuticals Limited | 31f3c720-1597-4d43-9296-33017b90b15f | 2023-01-11 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
| Theophylline | THEOPHYLLINE | Teva Pharmaceuticals, Inc. | 25eabefa-518b-4030-9b72-01ac8b3deba9 | 2022-04-01 | Warnings, Adverse reactions | 317769 314241 |
| Theophylline | THEOPHYLLINE | Alembic Pharmaceuticals Inc. | 77e849b8-900b-4f0d-ac5c-1391abcd5721 | 2021-10-01 | Warnings, Adverse reactions | 317769 314241 0I55128JYK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.